Investors_Hero.jpg

FibroGen Investor FAQ

  • On which exchange and under what symbol are FibroGen’s shares traded?

    • FibroGen is listed on the NASDAQ Global Market under the ticker symbol FGEN.

  • What is your stock’s CUSIP?

    • 31572Q

  • Where is FibroGen, Inc. incorporated?

    • FibroGen is incorporated in the State of Delaware.

  • Where is FibroGen headquartered?

    • FibroGen, Inc., headquarters are located at 409 Illinois Street, San Francisco, CA 94158.

  • How can I purchase or sell shares?

    • Shares may be purchased or sold through a stockbroker of your choice.

  • Can I purchase shares directly from the company?

    • No, FibroGen, Inc., does not have a direct stock purchase plan. Shares may be purchased through a stockbroker of your choice.

  • Do you anticipate paying a dividend?

    • FibroGen, Inc., does not foresee paying a dividend in the near future.

  • Who is FibroGen’s Transfer Agent?

    • American Stock Transfer & Trust Company LLC
      6201 15th Avenue
      Brooklyn, NY 11219
      www.amstock.com
      info@amstock.com
      Tel: 800-937-5449 (US toll-free)
      Tel: 718-921-8124 (from outside the US)

  • Who should I notify in the event of lost stock certificates, or a change of address?

    • Our shares are uncertificated. However, communication regarding change of address should be directed to our transfer agent, American Stock Transfer & Trust Company LLC, if you hold shares directly, or with your stockbroker if you purchased shares on the open market.

  • Who are FibroGen’s independent auditors?

    • PricewaterhouseCoopers LLP
      488 Almaden Blvd, Suite 1800
      San Jose, CA 95110

  • Who can I contact if I have an Investor Relations question?